100 Years of Research: Insights Into Evolution of Vaccine Development
Much like the scientist who led the first research lab at CHOP in 1922, our Bench to Bedside guest, Dr. Paul Offit, director of the…
Course Instructor: Paul A. Offit, MD
Where We Are Now with Dr. Paul Offit: Vaccines
How do the COVID-19 vaccines work? How concerned should we be about the new COVID-19 variants? Dr. Paul Offit, Director of CHOP’s Vaccine Education Center, is…
Pediatric Partners COVID-19 Town Hall: Current State, Omicron Variant, Vaccines, and Preparing for the Holidays
Please join us for a timely COVID-19 Update for a comprehensive review on the current state of COVID-19. Discussion will include an update on the…
Vaccine Conversations: Why Do Unvaccinated People Pose a Risk to Vaccinated People?
You may have wondered why unvaccinated people pose a risk to vaccinated people or why “my body, my choice” is different for vaccines. If so,…
Vaccine Conversations: Vaccines and Breastfeeding
If you’re breastfeeding, you may have questions about your baby’s vaccines. Watch Dr. Paul Offit, Director of the Vaccine Education Center, and Dr. Amna Husain,…
Vaccine Conversations: What We Know About Vaccines, the Immune System and Autoimmunity
If you’re a parent, you likely have a lot of questions about your children’s vaccines. Watch Dr. Paul Offit, Director of the Vaccine Education Center,…
COVID Update: Vaccines for 5-11 Year Olds
BREAKING NEWS EPISODE: Dr. Paul Offit rejoins us to speak about vaccines for 5-11 year olds! A Pediatric Emergency Medicine Podcast to educate, enlighten and inform.…
Pediatric Partners COVID-19 Town Hall: Facing the 2021-22 Fall/Winter Challenges in Pediatrics
Please join us for our monthly COVID-19 update for a comprehensive review on recent variants and spread, vaccines, trials, immunity and boosters, and how to…
A Conversation with Dr. Paul Offit
Dr. Paul Offit discusses his latest book, OVERKILL: When Modern Medicine Goes Too Far and COVID Updates from the Expert. Topics include: use of anti-pyretics…
Developing a SARS-CoV-2 Vaccine
At the conclusion of this session, participants will be able to understand the current status of the SARS-CoV-2 vaccine by first comparing a typical vaccine…